Research and progress of inflammasomes in nonalcoholic fatty liver disease

被引:4
作者
Chen, Ke-qian
Ke, Bo-yi
Cheng, Lu
Yu, Xiao-qing
Wang, Zong-bao
Wang, Shu-zhi [1 ]
机构
[1] Univ South China, Inst Pharm & Pharmacol, Sch Pharmaceut Sci, Hengyang Med Sch, Hengyang 421001, Peoples R China
关键词
Nonalcoholic fatty liver disease; NLRP3; Nonalcoholic steatohepatitis; Liver inflammation; Steatosis; Fibrosis; NLRP3; INFLAMMASOME; HEPATIC STEATOSIS; ACTIVATION; STEATOHEPATITIS; HOMEOSTASIS; PATHWAY; MICE;
D O I
10.1016/j.intimp.2023.110013
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
With the development of the social economy, unhealthy living habits and eating styles are gradually affecting people's health in recent years. As a chronic liver disease, NAFLD is deeply affected by unhealthy living habits and eating styles and has gradually become an increasingly serious public health problem. As a protein complex in clinical research, the inflammasomes play a crucial role in the development of NAFLD, atherosclerosis, and other diseases. This paper reviews the types, composition, characteristics of inflammasomes, and molecular mechanism of the inflammasome in NAFLD. Meanwhile, the paper reviews the drugs and non-drugs that target NLRP3 inflammasome in the treatment of NAFLD in the past decades. we also analyzed and summarized the related experimental models, mechanisms, and results of NAFLD. Although current therapeutic strategies for NAFLD are not effective, we expect that we will be able to find an appropriate treatment to address this problem in the future with further research on inflammasome.
引用
收藏
页数:9
相关论文
共 101 条
[1]   Steatosis, inflammasome upregulation, and fibrosis are attenuated in miR-155 deficient mice in a high fat-cholesterol-sugar diet-induced model of NASH [J].
Bala, Shashi ;
Ganz, Michal ;
Babuta, Mrigya ;
Zhuang, Yuan ;
Csak, Timea ;
Calenda, Charles D. ;
Szabo, Gyongyi .
LABORATORY INVESTIGATION, 2021, 101 (12) :1540-1549
[2]   Human NLRP1: From the shadows to center stage [J].
Bauernfried, Stefan ;
Hornung, Veit .
JOURNAL OF EXPERIMENTAL MEDICINE, 2021, 219 (01)
[3]  
Cabrera D., SCI REP
[4]   NLRP12 collaborates with NLRP3 and NLRC4 to promote pyroptosis inducing ganglion cell death of acute glaucoma [J].
Chen, Hui ;
Deng, Yang ;
Gan, Xiaoliang ;
Li, Yonghao ;
Huang, Wenyong ;
Lu, Lin ;
Wei, Lai ;
Su, Lishi ;
Luo, Jiawen ;
Zou, Bin ;
Hong, Yanhua ;
Cao, Yihai ;
Liu, Yizhi ;
Chi, Wei .
MOLECULAR NEURODEGENERATION, 2020, 15 (01)
[5]   NLRP12 attenuates colon inflammation by maintaining colonic microbial diversity and promoting protective commensal bacterial growth [J].
Chen, Liang ;
Wilson, Justin E. ;
Koenigsknecht, Mark J. ;
Chou, Wei-Chun ;
Montgomery, Stephanie A. ;
Truax, Agnieszka D. ;
Brickey, W. June ;
Packey, Christopher D. ;
Maharshak, Nitsan ;
Matsushima, Glenn K. ;
Plevy, Scott E. ;
Young, Vincent B. ;
Sartor, R. Balfour ;
Ting, Jenny P-Y .
NATURE IMMUNOLOGY, 2017, 18 (05) :541-551
[6]   Adropin protects against liver injury in nonalcoholic steatohepatitis via the Nrf2 mediated antioxidant capacity [J].
Chen, Xu ;
Xue, Hongliang ;
Fang, Wanjun ;
Chen, Ke ;
Chen, Shen ;
Yang, Wenqi ;
Shen, Tianran ;
Chen, Xuechen ;
Zhang, Peiwen ;
Ling, Wenhua .
REDOX BIOLOGY, 2019, 21
[7]   NLRC4 inflammasome activation regulated by TNF-α promotes inflammatory responses in nonalcoholic fatty liver disease [J].
Chen, Yihe ;
Ma, Kuifen .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 511 (03) :524-530
[8]   Qing-Chang-Hua-Shi granule ameliorates DSS-induced colitis by activating NLRP6 signaling and regulating Th17/Treg balance [J].
Cheng, Cheng ;
Hu, Jingyi ;
Li, Yanan ;
Ji, Yuejin ;
Lian, Ziyu ;
Au, Ryan ;
Xu, Feng ;
Li, Weiyang ;
Shen, Hong ;
Zhu, Lei .
PHYTOMEDICINE, 2022, 107
[9]   Both bone marrow-derived and non-bone marrow-derived cells contribute to AIM2 and NLRP3 inflammasome activation in a MyD88-dependent manner in dietary steatohepatitis [J].
Csak, Timea ;
Pillai, Arun ;
Ganz, Michal ;
Lippai, Dora ;
Petrasek, Jan ;
Park, Jin-Kyu ;
Kodys, Karen ;
Dolganiuc, Angela ;
Kurt-Jones, Evelyn A. ;
Szabo, Gyongyi .
LIVER INTERNATIONAL, 2014, 34 (09) :1402-1413
[10]   NLRP3 inhibitor glibenclamide attenuates high-fat diet and streptozotocin-induced non-alcoholic fatty liver disease in rat: studies on oxidative stress, inflammation, DNA damage and insulin signalling pathway [J].
Dwivedi, Durgesh Kumar ;
Jena, G. B. .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2020, 393 (04) :705-716